Divining what President Trump is thinking is not always an easy task, but biotech executive John Crowley believes he may have some insight — at least when it comes to Trump’s views on the Food and Drug Administration.
Earlier this week, Trump gave a major speech vowing to “slash restraints” at the FDA to speed drug approvals and he has previously promised to get rid 75 percent to 80 percent of regulations. Crowley is no mind reader, but after a private meeting with Trump at the White House before the speech, he came away with the impression that the president does not really want to unravel the FDA.
“From listening to him, I don’t get the sense that means that it’s about slash and burn, and that he wants to get rid of all the regulations,” said Crowley. “At least that’s the message I heard in our private conversation.”
About the Author Reprints
After a “private meeting” Prime Minister May also thought she had an idea that Our Dear Leader would be supportive. Good luck with that.